Dual Chamber Injection Devices to 2024

  • ID: 4437564
  • Report
  • Region: Global
  • 90 Pages
  • Greystone Associates
1 of 4

The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients has led to increasing interest in injection devices that can eliminate the number of steps required to reconstitute the drug and make it available for injection. Dual chamber syringes and injectors - devices that allow reconstitution to take place within the device immediately prior to injection - represent the most elegant engineering solution to this need. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding.

In terms of market penetration, dual chamber injection devices can be found in seven distinct therapeutic segments. We expect this number to grow as the influence of injectable biologicals on therapeutic practice increases. As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of these specialty devices will increase, reaching a therapeutic market value of $5.3 billion annually in 2024.

What You Will Learn

  • What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
  • What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
  • What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
  • What are the key dual chamber device selection factors, technologies and market development issues?
  • What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2024?
  • What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
  • How important are pharma-device alliances and design partnerships on dual chamber injection devices?
  • What is the impact of economic, technology, and regulatory factors?

Report Matrix - Who Should Read this Report

Development

  • Drug Developers
  • Device Suppliers
  • CMO's
  • Components/API's
  • Clinical Trial Management

Industry

  • Pharma Managers
  • Biotech Managers
  • Drug Marketers
  • Industry Strategists
  • Financial Analysts
  • Management Consultants

Market

  • Clinical Managers
  • Drug Distributers
  • Pharma Regulators
  • FDA Consultants
  • Managed Care Managers
READ MORE
Note: Product cover images may vary from those shown
2 of 4

1. Executive Summary

  • Specialty Injection Device Market Dynamics
  • Drug Formulation Evolution
  • Specialty Injection Device Demand Drivers
  • Chronic Conditions and Self-Administration
  • The Growth of Biologicals
  • Shifting Patient Demographics
  • Drug Economics, Safety and Compliance
  • Device Design and Innovation
  • Competitive Landscape
  • Technology Market Drivers

2. The Dual Chamber Injection Device Analysis

  • Dual Chamber Cartridges
  • Branded Devices
  • Supply Chain
  • Commercial Drug Products
  • Dual Chamber Injectors
  • Branded Devices
  • Supply Chain
  • Commercial Drug Products
  • Dual Chamber Syringes
  • Branded Devices
  • Supply Chain
  • Commercial Drug Products
  • Product-Specific Devices
  • Product Specific Device Development
  • Specialty Devices
  • OEM Devices

3. Dual Chamber Therapeutic Segments - Market Data & Forecasts

  • Glycemic Control
  • Hereditary Conditions
  • Hormone Replacement
  • Infectious Disease
  • Metabolic Conditions
  • Oncology
  • Reproductive Health
  • Other Therapeutic Segments

4. Market Factors

  • Device Product Strategies
  • Device Economics
  • Product Branding
  • Direct-to-Consumer Marketing
  • Managed Care Trends

5 Company Profiles

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.
  • Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.
  • Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll